IVD China last week: Leica Biosystems and YZY Medical, YHLO, Merck, Xilong Scientific

Leica Biosystems and YZY Medical Forge Strategic Partnership

Recently, Wuhan YZY Medical Science & Technology ("YZY Medical") and Leica Biosystems (Shanghai) Co., Ltd. ("Leica Biosystems") signed a strategic partnership agreement at the Optics Valley Biopharmaceutical Accelerator in Wuhan's East Lake High-Tech Zone, officially becoming strategic partners. This collaboration aims to integrate the technical and resource advantages of both parties in the Fluorescence In Situ Hybridization (FISH) platform to jointly advance the development and application of precision medical technologies. To further promote the "four modernizations" of the smart pathology industry and enhance the level of cancer precision diagnosis and treatment in China, both parties will leverage their respective molecular detection technology platforms to safeguard public health together. The signing marks the official launch of in-depth cooperation between the two parties in molecular pathology diagnostics. With a customer-oriented approach, they aim to empower each other and bring better products to market. Adhering to the philosophy of win-win cooperation, both companies will fully utilize their respective strengths and resources to safeguard life and health with high-quality products and services, driving continuous progress in the field of tumor precision medicine.

1 Billion RMB Investment! Hunan YHLO Medical Device Innovation Ecosystem Park

The Hunan YHLO Medical Device Innovation Ecosystem Park has a total investment of 1 billion RMB and covers an area of 150 mu (approximately 10 hectares). The facility has already completed construction with a total floor area of 102,400 square meters. As the largest industrial project outside of its Shenzhen headquarters, the opening of the Hunan YHLO Medical Device Innovation Ecosystem Park holds significant strategic importance for YHLO. It not only advances the integration of production, education, research, and application but also accelerates the commercialization and application of technological achievements. After completion, the Hunan subsidiary of YHLO will collaborate with the company's R&D centers in Japan and Changsha to focus on research, development, and production in the field of in vitro diagnostics (IVD). The park will primarily support the R&D and production of YHLO's high-speed biochemical analyzers and microfluidic products, aiming to overcome technical bottlenecks and achieve mass production.

Merck and East China University of Science and Technology Establish Collaboration

The biopharmaceutical industry is a knowledge- and technology-intensive sector where top-tier professional talent is essential for enhancing industry competitiveness. To better support talent development, foster innovation, Merck China and East China University of Science and Technology (ECUST) held a university-enterprise cooperation signing and certification ceremony on December 17 at Merck’s M Lab™ Collaboration Center in Shanghai’s Zhangjiang Science City. Through a multifaceted collaboration model—including the establishment of a practical teaching base, industry-academia-research partnerships, and the development of dual-professional teaching teams—the partnership aims to achieve resource sharing and complementary strengths between the university and the enterprise. Both parties expressed their commitment to jointly advancing the integration of education and industry in biopharmaceuticals. This initiative not only broadens learning and practical platforms for students but also creates diverse employment opportunities. Together, Merck and ECUST will explore new pathways for cultivating high-quality talent in the biopharmaceutical industry, paving the way for deeper collaboration and innovative development.

Xilong Scientific Deepens Cooperation in Thailand, Advancing Overseas Strategic Expansion

Xilong Scientific (002584) has signed a strategic cooperation agreement with Complete Link Trading (CLT) in Bangkok, Thailand. The signing ceremony was attended by Mr. Phinij Jarusombat, former Deputy Prime Minister of Thailand and Chairman of the Thai-Chinese Cultural and Economic Association; Mr. Vasin Ruangprateepsaeng, former Thai Ambassador to the Philippines and former Thai Consul General in Guangzhou; Mr. Suthep and Mr. Somchai, Vice Chairmen of the Thai-Chinese Cultural and Economic Association; as well as Mr. Zhao Ye, President of Xilong Scientific, and Vice Presidents Mr. Qi Hongbo and Mr. Niu Jia. As a leading Chinese manufacturer and integrated supplier of large-scale chemical reagents, Xilong Scientific is known for its outstanding manufacturing capabilities and efficient supply chain management, delivering high-quality services to its customers. Thailand, being a key market in Southeast Asia and a significant driver of regional economic growth, presents enormous opportunities. CLT’s industry insights and resource advantages in Thailand, combined with Xilong Scientific’s technical expertise and supply chain capabilities in the chemical reagent field, create a perfect synergy. Through this strong collaboration, Xilong Scientific aims to provide Thai customers with more efficient and reliable chemical solutions, while supporting the industrial upgrading and development of the local market.